ADMA Biologics

ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases.

Articles by ADMA Biologics

MICRO-ELISA Assay Launched to Detect SARS-CoV-2 Neutralizing Antibodies in Plasma

by ADMA Biologics

ImmunoRank offers a faster, simpler, more cost effective way to identify high titer convalescent plasma for use in both treating covid-19 patients and for creating covid-19 hyperimmune globulins